New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation
F.G. Cosio, Y. Kudva, M. van der Velde New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation Kidney Int 67 2005 2415
Post-transplant diabetes mellitus: Increasing incidence in renal allograft recipients transplanted in recent years
F.G. Cosio, T.E. Pesavento, K. Osei Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years Kidney Int 59 2001 732
Early pulse pressure and low grade proteinuria as independent long-term risk factors for new-onset diabetes after kidney transplantation
M. Roland, P. Gatault, A. Al-Naijjar Early pulse pressure and low grade proteinuria as independent long-term risk factors for new-onset diabetes after kidney transplantation Am J Transplant 8 2008 1719
Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins)
G.V.R. Prasad, S.J. Kim, M. Huang Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins) Am J Transplant 4 2004 1897
Incidence and cost of new onset diabetes mellitus among US waitlisted and transplanted renal allograft recipients
R.S. Woodwards, M.A. Schnitzler, J. Baty Incidence and cost of new onset diabetes mellitus among US waitlisted and transplanted renal allograft recipients Am J Transplant 3 2003 590
Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
ALLHAT Collaborative Research Group
J.I. Barzilay, B.R. Davis, J.A. Cutler ALLHAT Collaborative Research Group Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Arch Intern Med 166 2006 2191